Victoria Bae-Jump, MD, PhD, has recently been awarded two grants to further cancer research initiatives: a two-year, $180,000 Collaborative Funding Grant from the North Carolina Biotechnology Center, and a four-year, $800,000 Research Scholar grant from the American Cancer Society.
Joseph M. DeSimone, Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, has been named the recipient of the inaugural $250,000 Kabiller Prize in Nanoscience and Nanomedicine for his invention and use of PRINT, a breakthrough technology that has been used to make advances toward the development of new cancer treatments, inhalable therapeutics and next generation vaccines for malaria, pneumonia and dengue.
Mortality risk from opioid overdose has previously been measured in terms of thresholds of risk. Four scientists, including UNC Lineberger member Kurt Ribisl, PhD, are co-authors on a new cohort study finding that dose-dependent opioid overdose risk among patients does not show evidence of a distinct risk threshold.
Matthew Milowsky, MD, a UNC Lineberger member and associate professor in the University of North Carolina School of Medicine, is the principle investigator for a large-scale, genomically driven bladder cancer study that will be the first project of the Bladder Cancer Genomics Consortium. The consortium is a collaborative effort between Bladder Cancer Advocacy Network, a not-for-profit patient advocacy organization, and eight institutions.
Bryce Reeve, PhD, a UNC Lineberger member and professor in the UNC Gillings School of Global Public Health Department of Health Policy and Management, has received a more than $2.9 million, four-year grant from the NIH as part of its Pediatric Patient-Reported Outcomes in Chronic Disease consortium. The grant is shared with Duke University where Laura Schanberg, MD, is the co-P.I.